Key Takeaways
CCSD code 1552B is the CCSD Schedule code for a Haemoglobin F (HbF) level blood test, a pathology investigation — not a surgical or procedural code.
It sits within the Pathology part of the CCSD Schedule of Diagnostic Tests. Pathology codes take their specimen type from the last letter of the code, and “B” denotes a blood specimen.
HbF level is used to help investigate and monitor haemoglobinopathies such as beta-thalassaemia and sickle cell disease, and to identify hereditary persistence of fetal haemoglobin (HPFH).
Fees for 1552B are set independently by each UK private medical insurer. Recognition is common across major insurers’ diagnostic schedules, but rates and cover vary — always confirm with the insurer’s own fee schedule before invoicing.
CCSD code 1552B is the CCSD Schedule code for a Haemoglobin F (HbF) level blood test, used to help investigate and monitor haemoglobinopathies such as beta-thalassaemia and sickle cell disease. This guide covers what the code represents clinically, which UK insurers recognise it, and how to document and submit a compliant claim through Healthcode.
CCSD code 1552B: test definition and clinical scope
CCSD code 1552B is the CCSD Schedule code for a Haemoglobin F (HbF) level blood test. It’s a diagnostic pathology investigation, not a surgical or procedural code — a distinction worth stating plainly, because the code number alone gives no clue to that.
Haemoglobin F, or fetal haemoglobin, is the predominant type of haemoglobin produced during fetal life. It normally falls sharply after birth as production switches to adult haemoglobin, and by around a year old it usually makes up less than 1% of total haemoglobin.
An HbF level test measures how much fetal haemoglobin remains in a blood sample, typically using high-performance liquid chromatography (HPLC) or an alkali denaturation method.
It sits within the Pathology part of the CCSD Schedule of Diagnostic Tests, maintained by the Clinical Coding and Schedule Development (CCSD) Group.
Haematology describes the clinical subject matter of the test here, not a separate CCSD specialty chapter — pathology specimen-letter codes like 1552B all sit within the Diagnostic schedule’s Pathology chapter, while Haematology is a distinct chapter of the Procedural schedule.
Pathology codes in the CCSD Diagnostic schedule are built differently from the anatomically driven Procedural schedule. The last letter of the code identifies the specimen type rather than a procedure variant: B for blood, C for cerebrospinal fluid, F for faeces, and so on.
That’s why 1552B ends in “B” — it’s a blood-specimen pathology test, not a bilateral variant, an assistant-billing modifier, or any other procedural convention. Those conventions belong to a different part of the schedule and don’t apply here.
Providers should still verify the exact narrative against the current CCSD Technical Guide (October 2025) before billing, as full schedule access requires a registered CCSD login. This Pabau guide covers what CCSD code 1552B represents clinically, how it’s recognised across UK private insurers, how to document and submit a compliant claim, and what causes rejections.
What CCSD code 1552B covers
Clinicians order an HbF level test when investigating a suspected haemoglobinopathy — an inherited disorder affecting the structure or production of haemoglobin. The three main clinical contexts are as follows.
- Beta-thalassaemia: HbF is often raised as a compensatory response when normal adult haemoglobin production is reduced, so measuring it helps characterise the severity of the condition.
- Sickle cell disease: HbF level is relevant both to diagnosis and to monitoring treatment, since higher HbF levels are protective against sickling and hydroxyurea therapy works partly by raising HbF.
- Hereditary persistence of fetal haemoglobin (HPFH): a benign genetic condition where HbF production continues into adulthood without other haematological abnormalities. An HbF level test can help distinguish HPFH from a more clinically significant haemoglobinopathy.
It’s also requested as part of a broader haemoglobinopathy work-up alongside a full blood count and haemoglobin electrophoresis, particularly where family history, ethnic background, or an abnormal routine blood count first raises suspicion.
For practices managing pathology test referrals, keeping the request form clear about why the test was ordered makes the difference between a claim insurers pay first time and one they query.
The specimen requirement is a standard venous blood draw, usually into an EDTA tube, with no special patient preparation beforehand.
Which UK insurers recognise CCSD code 1552B
CCSD codes are the industry standard that UK private medical insurers build their diagnostic fee schedules around, so 1552B is generally recognisable across the major insurers. That said, recognition of any specific code, and the benefit paid against it, is set by each insurer individually — the CCSD Group itself does not set fees.
Insurers such as Bupa, AXA Health, Aviva, Vitality Health, WPA, and Allianz Care all base their diagnostic fee schedules on CCSD coding.
As our Bupa CCSD codes guide explains, the same code can attract a different benefit from one insurer to the next, even for identical clinical work — so always check the specific insurer’s current fee schedule or code search tool before invoicing, rather than assuming a rate.
- Bupa: Diagnostic codes checked via the Bupa code search portal.
- AXA Health: Test codes verified through the AXA specialist forms portal.
- Aviva: CCSD-based fee schedule published on the Aviva provider portal.
- Vitality Health: Fee finder tool allows per-code fee lookup for recognised tests.
- WPA: Published fee schedule available via the WPA medical fees page.
- Allianz Care: National fee schedule (PDF) includes standard CCSD diagnostic codes.
Pro Tip
Before invoicing with CCSD code 1552B, log in to the relevant insurer’s provider portal and confirm both recognition and the current benefit for this code. Because it’s a diagnostic pathology code, don’t apply procedural conventions such as bilateral uplift or assistant billing — those rules don’t exist for this code.

Documentation requirements for CCSD code 1552B
Poor documentation is the leading cause of queries on diagnostic pathology claims generally, and CCSD code 1552B is no exception. Insurers expect the clinical record to substantiate the code, not merely assert it.
The record should support the clinical indication, the requesting consultant, and the specimen details that justify billing 1552B. Digital clinical forms that prompt for each required field reduce the risk of incomplete records at the point of care.
Practices handling haematology test results should also ensure their GDPR compliance covers storage of test results and laboratory reports where these support the billing record — the Information Commissioner’s Office (ICO) treats clinical test results as special-category personal data.
Submit CCSD diagnostic claims with fewer denials
Practice management software like Pabau helps UK private practices manage CCSD-coded pathology billing from documentation through to insurer submission — all within the same platform used for scheduling, clinical notes, and patient records.
How to submit a claim using CCSD code 1552B
UK private healthcare claims are increasingly submitted electronically through Healthcode, the industry’s designated clearing house. Most major PMIs, including Bupa and AXA Health, require or strongly prefer electronic submission via Healthcode over paper invoices.
The workflow for submitting a 1552B claim follows a standard sequence.
- Confirm prior authorisation: check whether the insurer requires authorisation before the test. Record the authorisation reference number before proceeding, where one is issued.
- Complete the clinical record: document the clinical indication, requesting consultant, and specimen details at the time of the request, not retrospectively.
- Generate the invoice: assign CCSD code 1552B as the diagnostic test code. Add any additional tests, such as a full blood count or haemoglobin electrophoresis, as separate line items rather than bundled under 1552B.
- Submit via Healthcode: upload the invoice through your practice management system’s Healthcode integration. Include the patient’s insurer membership number, authorisation reference, and the requesting consultant’s recognition number.
- Track the claim: monitor the claim status through the remittance advice. Queries on missing evidence of medical necessity are one of the more common reasons a diagnostic claim gets held up.
Common billing errors with CCSD code 1552B
Most claim rejections involving CCSD code 1552B fall into a handful of preventable categories.
Pro Tip
Run a periodic audit of CCSD code 1552B claims: confirm the clinical indication recorded matches a genuine haemoglobinopathy work-up, and check that no procedural billing conventions — bilateral uplift, assistant fees, anaesthetic co-billing — have been applied to what is a diagnostic pathology code.
Related CCSD blood-specimen pathology codes
Selecting the correct code from a group of related pathology codes matters because insurers validate clinical logic, not just the specimen letter. A “B” ending only confirms the specimen was blood — it doesn’t mean the codes below are clinically related to each other, or to 1552B.
Verify exact code narratives against the current CCSD schedule. Code descriptions are confirmed in the CCSD Technical Guide, which is updated periodically. Providers without CCSD login access can request one at ccsd.org.uk.
Billing CCSD code 1552B with practice management software
Manual claim preparation for CCSD codes creates avoidable errors. A test code entered incorrectly, a missing authorisation number, or an invoice sent to the wrong insurer portal can each delay payment by weeks.
UK private practices that process regular haematology or pathology test referrals benefit from claims management software that integrates CCSD code lookup, Healthcode submission, and claim status tracking in one workflow.
Practice management software like Pabau lets practices attach the correct code at the point of booking and carry it through to invoicing without re-entering data. It also supports structured clinical note templates, so documentation matches what insurers expect when reviewing diagnostic pathology claims.
Conclusion
CCSD code 1552B is a diagnostic pathology code for a Haemoglobin F (HbF) level blood test, not a procedural or surgical code. Once that’s clear, the billing itself is straightforward: confirm the clinical indication, get pre-authorisation where required, document the specimen and requesting consultant, and submit through Healthcode without applying any procedural conventions.
Pabau’s claims management software helps UK private practices submit CCSD-coded diagnostic claims accurately, track authorisations, and maintain audit-ready records without manual overhead. To see how Pabau handles the full private billing workflow, book a demo.
Continue your research
Need a complete reference for Bupa procedure and diagnostic codes? Bupa CCSD codes guide covers the full CCSD schedule, insurer fee framework, and electronic submission workflow for UK private providers.
Billing a related blood-specimen pathology code? Our 0153B billing guide covers the kaolin clotting time and its documentation requirements.
Thinking about the shift from NHS to private practice? Leaving the NHS for private practice provides a practical overview of the operational and billing differences to prepare for.
Frequently asked questions
What does CCSD code 1552B cover?
CCSD code 1552B is the CCSD Schedule code for a Haemoglobin F (HbF) level blood test — a diagnostic pathology investigation used to help assess haemoglobinopathies such as beta-thalassaemia and sickle cell disease, and to identify hereditary persistence of fetal haemoglobin (HPFH).
Is CCSD code 1552B a surgical or procedural code?
No. CCSD code 1552B sits in the Pathology part of the CCSD Schedule of Diagnostic Tests, not the procedural schedule. It’s a laboratory blood test, so procedural conventions such as bilateral billing, surgical assistant codes, or anaesthetic co-billing don’t apply to it.
Why does the code end in “B”?
In the CCSD Diagnostic schedule, pathology codes take the last letter of the code from the specimen type, not from a procedure variant. “B” means the specimen is blood. Other CCSD codes ending in “B”, such as 0153B or 0230B, cover entirely different tests — they simply share the same blood specimen letter, not a clinical relationship with 1552B.
Which UK private medical insurers recognise CCSD code 1552B?
1552B is generally recognisable across the major UK private medical insurers’ diagnostic fee schedules, including Bupa, AXA Health, Aviva, Vitality Health, WPA, and Allianz Care. Each insurer sets its own benefit independently, so confirm current recognition and rates via the insurer’s own fee schedule or code search tool before invoicing.
What documentation is required to bill CCSD code 1552B?
The clinical record should include the clinical indication (such as suspected haemoglobinopathy or monitoring of sickle cell disease treatment), the requesting consultant’s details, specimen collection information, the laboratory and method used, the patient’s insurer membership number, and a pre-authorisation reference where required.
How do I submit a CCSD code 1552B claim electronically?
Submit through Healthcode, the UK private healthcare electronic clearing house. Include the patient’s PMI membership number, pre-authorisation reference (where applicable), the requesting consultant’s insurer recognition number, and CCSD code 1552B as the diagnostic test code, with any additional tests on separate invoice lines.